Skip to main content
Top
Published in: Rheumatology International 3/2014

01-03-2014 | Original Article

Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province

Authors: Yan-Feng Zou, Chen-Chen Feng, Ji-Min Zhu, Jin-Hui Tao, Gui-Mei Chen, Qian-Ling Ye, Han Cen, Rui-Xue Leng, Fa-Ming Pan, Hai-Feng Pan, Rui Li, Yin-Guang Fan, Bin Wang, Xiang-Pei Li, Feng-Yu Zhang, Dong-Qing Ye

Published in: Rheumatology International | Issue 3/2014

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a severe complex rheumatic disease, but good estimate of its prevalence and risk factors is lacking in China. The aim of the study was to explore the prevalence of SLE and risk factors in rural areas of Anhui Province of China. Eleven counties were randomly selected in Anhui Province, and then, 15 % of the villages in selected counties were randomly sampled as study sites. Patients with SLE were identified through two phases. Based on the cases identified, a population-based case–control study was designed to examine risk factors associated with SLE. A total of 1,253,832 individuals and identified 471 SLE cases were surveyed. Crude and age-standardized prevalence were estimated at 37.56 and 36.03 per 100,000 persons, respectively. Gender difference in the prevalence of SLE was significant (P = 4.62 × 10−76), and the age-standardized prevalence was 6.17 for males and 67.78 for females per 100,000 persons. The distribution of SLE prevalence was significant by age group (P = 1.78 × 10−53), and the peak prevalence was observed at 40–50 years. Multiple environmental factors were associated with SLE, including birth conditions, sweet food, cooking oil, taste, fruit consumption, sunlight exposure, quality of sleep, physical activities, drinking water, residence, negative life events, hepatitis B vaccine, age of menarche, and age at birth of first child (P < 0.05). Our large population-based epidemiological survey estimated the prevalence of SLE at 37.56 per 100,000 persons. Multiple environmental factors were associated with the development of SLE.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ye DQ (2006) Systemic lupus erythematosus, 1st edn. People’s Health Publishing House, Beijing Ye DQ (2006) Systemic lupus erythematosus, 1st edn. People’s Health Publishing House, Beijing
2.
go back to reference Hess EV, Farhey Y (1995) Etiology, environmental relationships, epidemiology, and genetics of systemic lupus erythematosus. Curr Opin Rheumatol 7:371–375PubMedCrossRef Hess EV, Farhey Y (1995) Etiology, environmental relationships, epidemiology, and genetics of systemic lupus erythematosus. Curr Opin Rheumatol 7:371–375PubMedCrossRef
3.
go back to reference Manzi S (2001) Epidemiology of systemic lupus erythematosus. Am J Manag Care 7:S474–S479PubMed Manzi S (2001) Epidemiology of systemic lupus erythematosus. Am J Manag Care 7:S474–S479PubMed
4.
go back to reference Siegel M, Lee SL (1973) The epidemiology of systemic lupus erythematosus. Semin Arthr Rheum 3:1–54CrossRef Siegel M, Lee SL (1973) The epidemiology of systemic lupus erythematosus. Semin Arthr Rheum 3:1–54CrossRef
5.
go back to reference Borchers AT, Naguwa SM, Shoenfeld Y et al (2010) The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9:A277–A287PubMedCrossRef Borchers AT, Naguwa SM, Shoenfeld Y et al (2010) The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9:A277–A287PubMedCrossRef
6.
go back to reference Pons-Estel GJ, Alarcón GS, Scofield L et al (2010) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthr Rheum 39:257–268CrossRef Pons-Estel GJ, Alarcón GS, Scofield L et al (2010) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthr Rheum 39:257–268CrossRef
7.
go back to reference Osio-Salido E, Manapat-Reyes H (2010) Epidemiology of systemic lupus erythematosus in Asia. Lupus 19:1365–1373PubMedCrossRef Osio-Salido E, Manapat-Reyes H (2010) Epidemiology of systemic lupus erythematosus in Asia. Lupus 19:1365–1373PubMedCrossRef
8.
go back to reference Zeng QY, Chen R, Darmawan J et al (2008) Rheumatic diseases in China. Arthr Res Ther 10:R17CrossRef Zeng QY, Chen R, Darmawan J et al (2008) Rheumatic diseases in China. Arthr Res Ther 10:R17CrossRef
9.
go back to reference Dai SM, Han XH, Zhao DB et al (2003) Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol 30:2245–2251PubMed Dai SM, Han XH, Zhao DB et al (2003) Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol 30:2245–2251PubMed
10.
go back to reference Chou CT, Pei L, Chang DM et al (1994) Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 21:302–306PubMed Chou CT, Pei L, Chang DM et al (1994) Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 21:302–306PubMed
12.
go back to reference Mok C (2011) Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 20:767–771PubMedCrossRef Mok C (2011) Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 20:767–771PubMedCrossRef
13.
go back to reference Chiu YM, Lai CH (2010) Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 19:1250–1255PubMedCrossRef Chiu YM, Lai CH (2010) Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 19:1250–1255PubMedCrossRef
14.
go back to reference Cooper GS, Wither J, Bernatsky S et al (2010) Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology 49:2172–2180PubMedCrossRef Cooper GS, Wither J, Bernatsky S et al (2010) Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology 49:2172–2180PubMedCrossRef
15.
go back to reference Dooley MA, Hogan SL (2003) Environmental epidemiology and risk factors for autoimmune disease. Curr Opin Rheumatol 15:99–103PubMedCrossRef Dooley MA, Hogan SL (2003) Environmental epidemiology and risk factors for autoimmune disease. Curr Opin Rheumatol 15:99–103PubMedCrossRef
16.
go back to reference Peng CL, Jiang F, Wang BT et al (2010) Interactions between susceptible genes and risk environmental factors in Chinese females with systemic lupus erythematosus. Zhonghua Yu Fang Yi Xue Za Zhi 44:144–149PubMed Peng CL, Jiang F, Wang BT et al (2010) Interactions between susceptible genes and risk environmental factors in Chinese females with systemic lupus erythematosus. Zhonghua Yu Fang Yi Xue Za Zhi 44:144–149PubMed
17.
go back to reference Ye DQ, Hu YS, Li XP et al (2004) Influences of environmental factors and interaction of several chemokines gene-environmental on systemic lupus erythematosus. Zhonghua Liu Xing Bing Xue Za Zhi 25:949–953PubMed Ye DQ, Hu YS, Li XP et al (2004) Influences of environmental factors and interaction of several chemokines gene-environmental on systemic lupus erythematosus. Zhonghua Liu Xing Bing Xue Za Zhi 25:949–953PubMed
18.
go back to reference Huang LS (2002) The census 2000 in Anhui Province, 1st edn. China Statistics Press, Beijing Huang LS (2002) The census 2000 in Anhui Province, 1st edn. China Statistics Press, Beijing
19.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 40:1725CrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 40:1725CrossRef
20.
go back to reference Jiménez S, Cervera R, Font J et al (2003) The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 25:3–12PubMedCrossRef Jiménez S, Cervera R, Font J et al (2003) The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 25:3–12PubMedCrossRef
21.
go back to reference Cervera R, Khamashta MA, Font J et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on systemic lupus erythematosus. Medicine 72:113–124PubMedCrossRef Cervera R, Khamashta MA, Font J et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on systemic lupus erythematosus. Medicine 72:113–124PubMedCrossRef
22.
go back to reference Gudmundsson S, Steinsson K (1990) Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J Rheumatol 17:1162–1167PubMed Gudmundsson S, Steinsson K (1990) Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J Rheumatol 17:1162–1167PubMed
23.
go back to reference Jonsson H, Nived O, Sturfelt G et al (1990) Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol 29:185–188PubMedCrossRef Jonsson H, Nived O, Sturfelt G et al (1990) Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol 29:185–188PubMedCrossRef
24.
go back to reference Hochberg MC, Perlmutter DL, Medsger TA et al (1995) Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 4:454–456PubMedCrossRef Hochberg MC, Perlmutter DL, Medsger TA et al (1995) Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 4:454–456PubMedCrossRef
25.
go back to reference Washio M, Horiuchi T, Kiyohara C et al (2006) Smoking, drinking, sleeping habits, and other lifestyle factors and the risk of systemic lupus erythematosus in Japanese females: findings from the KYSS study. Mod Rheumatol 16:143–150PubMedCrossRef Washio M, Horiuchi T, Kiyohara C et al (2006) Smoking, drinking, sleeping habits, and other lifestyle factors and the risk of systemic lupus erythematosus in Japanese females: findings from the KYSS study. Mod Rheumatol 16:143–150PubMedCrossRef
26.
27.
go back to reference Ghaussy NO, Sibbitt WL Jr, Qualls CR (2001) Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. J Rheumatol 28:2449–2453PubMed Ghaussy NO, Sibbitt WL Jr, Qualls CR (2001) Cigarette smoking, alcohol consumption, and the risk of systemic lupus erythematosus: a case-control study. J Rheumatol 28:2449–2453PubMed
28.
go back to reference Wang J, Pan HF, Ye DQ et al (2008) Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis. Clin Rheumatol 27:1557–1563PubMedCrossRef Wang J, Pan HF, Ye DQ et al (2008) Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis. Clin Rheumatol 27:1557–1563PubMedCrossRef
Metadata
Title
Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province
Authors
Yan-Feng Zou
Chen-Chen Feng
Ji-Min Zhu
Jin-Hui Tao
Gui-Mei Chen
Qian-Ling Ye
Han Cen
Rui-Xue Leng
Fa-Ming Pan
Hai-Feng Pan
Rui Li
Yin-Guang Fan
Bin Wang
Xiang-Pei Li
Feng-Yu Zhang
Dong-Qing Ye
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 3/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2902-1

Other articles of this Issue 3/2014

Rheumatology International 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.